4.7 Article

Grading Pancreatic Neuroendocrine Tumors Via Endoscopic Ultrasound-guided Fine Needle Aspiration A Multi-institutional Study

Related references

Note: Only part of the references are listed.
Article Surgery

Molecular Genomic Assessment Using a Blood-based mRNA Signature (NETest) is Cost-effective and Predicts Neuroendocrine Tumor Recurrence With 94% Accuracy

Irvin M. Modlin et al.

Summary: The NETest is more accurate in predicting neuroendocrine tumor recurrence compared to CgA, with a 94% accuracy rate. Post-surgical NETest levels on day 30 were closely associated with recurrence, while CgA showed no utility in surgery.

ANNALS OF SURGERY (2021)

Review Oncology

Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms

Valentina Andreasi et al.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2020)

Article Endocrinology & Metabolism

The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia

Frediano Inzani et al.

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2018)

Article Medical Laboratory Technology

Interrater reliability: the kappa statistic

Mary L. McHugh

BIOCHEMIA MEDICA (2012)

Article Gastroenterology & Hepatology

EUS-FNA predicts 5-year survival in pancreatic endocrine tumors

Fatima A. F. Figueiredo et al.

GASTROINTESTINAL ENDOSCOPY (2009)

Review Gastroenterology & Hepatology

Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors

David C. Metz et al.

GASTROENTEROLOGY (2008)

Article Endocrinology & Metabolism

Endoscopic ultrasound in the localisation of pancreatic islet cell tumours

AM McLean et al.

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2005)